Early Access — free while we kick the tires
EdgarHawk

Arnold Cynthia A

Director

Director
2 filings analyzed · 1 company · Latest 2025-05-15

Companies

Company Buys Sells Direction
Fluence Energy, Inc. FLNC 2 0 Net buying

Activity

May 2025
2025-05-15 Fluence Energy, Inc. FLNC
medium
Buy
33,000 shares
$194,641
Significance 4/10

Director Cynthia A. Arnold buys 33.0K shares of FLNC at $5.90; stock now at $5.37, -79.1% from 52-week high.

Arnold purchased 33,000 shares on 2025-05-12 at $5.90, expanding her holdings by 62.0% to 86,202 shares, totaling $194.6K in investment. The stock has since declined to $5.37, trading 79.1% below its 52-week high of $25.65, suggesting a material pullback from recent peaks. Her prior buy at this ticker on 2025-02-13 followed a similar pattern: it resulted in a -21.8% 30-day return and -16.9% 90-day return, with a 0% win rate across her same-ticker history. Fundamentals show revenue growth of 21.7% year-over-year, but the company reported a net loss of $31.0M in the latest quarter against $431.6M in revenue, and the stock trades at a P/E of 29.83 while down 16.5% over the past 90 days—a context where the timing and conviction behind this incremental accumulation warrant close monitoring.

February 2025
2025-02-14 Fluence Energy, Inc. FLNC
high
Buy
10,000 shares
$65,600
Significance 6/10

FLNC Director Arnold buys 10,000 shares at $6.56; 4 other insiders bought within 14 days—stock down -74.9% from $25.65 peak

Director Cynthia A Arnold purchased 10,000 shares at $6.56, increasing her holdings by 31.4% to 41,861 shares total. This transaction is part of a cluster pattern: 4 other insiders also acquired shares within the past 14 days. The timing coincides with extreme downward price pressure—FLNC has declined -74.9% from its 52-week high of $25.65 and -59.1% over the past 30 days alone. Against this backdrop, the multi-insider purchase pattern suggests accumulated conviction at depressed levels, though the company simultaneously reports a net loss of $41,466,000 in the latest quarter despite revenue growth of +21.7% year-over-year. The clustering of director buys amid substantial stock deterioration warrants investor scrutiny of whether the price weakness reflects fundamental deterioration or creates a contrarian entry opportunity.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access